Data as of Nov 21
| +0.0008 / +0.19%|
Cytori Therapeutics, Inc. develops cell therapies based on autologous adipose-derived stem and regenerative cells to treat cardiovascular disease and repair soft tissue defects. It automates the extraction and preparation of clinical grade adipose-derived stem and regenerative cells using device, Celution system. The company sells its products to researchers at academic centers and hospitals to fulfill the demand for access to stem and regenerative cells at the point-of-care. It offers a range of products designed to optimize tissue harvest and graft delivery which include Cellbrush, a surgical instrument for precise delivery of micro droplets. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in San Diego, CA.
|Marc H. Hedrick||President, Chief Executive Officer & Director|
|Douglas M. Arm||Senior Vice President-Operations|
|Tiago Girão||Chief Financial Officer & Vice President|
|Steven Kesten||Chief Medical Officer & Executive Vice President|
|Seijiro Norio Shirahama||President-Asia Pacific|